Common use of Cumulative Effect of Royalty Reductions Clause in Contracts

Cumulative Effect of Royalty Reductions. In no event shall the royalty reductions described in this Section 6.6.4, alone or together, reduce the royalties payable by Celgene for a Binder Program Product in a country in any given Calendar Quarter to less than [***] percent ([***]%) of the amounts otherwise payable by Celgene for such Calendar Quarter. Celgene may carry over and apply any such royalty reductions, which are incurred or accrued in a Calendar Quarter and are not deducted in such Calendar Quarter due to the limitation set forth above in this Section 6.6.4(f), to any subsequent Calendar Quarter(s) and shall begin applying such reduction to such royalties as soon as practicable and continue applying such reduction on a Calendar Quarterly basis thereafter until fully deducted, in all cases subject to the limitation set forth above in this Section 6.6.4(f).

Appears in 2 contracts

Samples: License Agreement (Vividion Therapeutics, Inc.), License Agreement (Vividion Therapeutics, Inc.)

AutoNDA by SimpleDocs

Cumulative Effect of Royalty Reductions. In no event shall the royalty reductions described in this Section 6.6.49.4, alone or together, reduce the royalties payable by Celgene for a Binder Program Shared Product in a country in any given Calendar Quarter to less than [***] percent ([***]%) of the amounts otherwise payable by Celgene for such Shared Product in such country in such Calendar Quarter. Celgene may carry over and apply any such royalty reductions, which are incurred or accrued in a Calendar Quarter and are not deducted in such Calendar Quarter due to the limitation set forth above in this Section 6.6.4(f9.4(f), to any subsequent Calendar Quarter(s) and shall begin applying such reduction to such royalties as soon as practicable and continue applying such reduction on a Calendar Quarterly basis thereafter until fully deducted, in all cases subject to the limitation set forth above in this Section 6.6.4(f9.4(f).

Appears in 2 contracts

Samples: License Agreement (Vividion Therapeutics, Inc.), License Agreement (Vividion Therapeutics, Inc.)

Cumulative Effect of Royalty Reductions. In no event shall the royalty reductions described in this Section 6.6.49.2, alone or together, reduce the royalties payable by Celgene for a Binder Program Licensed Product in a country in any given Calendar Quarter to less than [***] percent ([***]%) of the amounts otherwise payable by Celgene for such Licensed Product in such country in such Calendar Quarter. Celgene may carry over and apply any such royalty reductions, which are incurred or accrued in a Calendar Quarter and are not deducted in such Calendar Quarter due to the limitation set forth above in this Section 6.6.4(f9.2(g), to any subsequent Calendar Quarter(s) and shall begin applying such reduction to such royalties as soon as practicable and continue applying such reduction on a Calendar Quarterly basis thereafter until fully deducted, in all cases subject to the limitation set forth above in this Section 6.6.4(f9.2(g).

Appears in 2 contracts

Samples: License Agreement (Vividion Therapeutics, Inc.), License Agreement (Vividion Therapeutics, Inc.)

Cumulative Effect of Royalty Reductions. In no event shall the royalty reductions described in this Section 6.6.49.3, alone or together, reduce the royalties payable by Celgene for a Binder Program Shared Product in a country in any given Calendar Quarter to less than [***] percent ([***]%) of the amounts otherwise payable by Celgene for such Shared Product in such country in such Calendar Quarter. Celgene may carry over and apply any such royalty reductions, which are incurred or accrued in a Calendar Quarter and are not deducted in such Calendar Quarter due to the limitation set forth above in this Section 6.6.4(f)9.4, to any subsequent Calendar Quarter(s) and shall begin applying such reduction to such royalties as soon as practicable and continue applying such reduction on a Calendar Quarterly basis thereafter until fully deducted, in all cases subject to the limitation set forth above in this Section 6.6.4(f)9.4.

Appears in 2 contracts

Samples: License Agreement (Vividion Therapeutics, Inc.), License Agreement (Vividion Therapeutics, Inc.)

Cumulative Effect of Royalty Reductions. In no event shall the royalty reductions described in this Section 6.6.49.3, alone or together, reduce the royalties payable by Celgene for a Binder Program Licensed Product in a country in any given Calendar Quarter to less than [***] ]percent ([***]%) of the amounts otherwise payable by Celgene for such Calendar Quarter. Celgene may carry over and apply any such royalty reductions, which are incurred or accrued in a Calendar Quarter and are not deducted in such Calendar Quarter due to the limitation set forth above in this Section 6.6.4(f9.3(f), to any subsequent Calendar Quarter(s) and shall begin applying such reduction to such royalties as soon as practicable and continue applying such reduction on a Calendar Quarterly basis thereafter until fully deducted, in all cases subject to the limitation set forth above in this Section 6.6.4(f9.3(f).

Appears in 1 contract

Samples: License Agreement (Agios Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Cumulative Effect of Royalty Reductions. In no event shall the royalty reductions described in this Section 6.6.49.5, alone or together, reduce the royalties payable by Celgene for a Binder Program Licensed Product in a country in any given Calendar Quarter to less than [***] percent ([***]%) of the amounts otherwise payable by Celgene for such Calendar Quarter. Celgene may carry over and apply any such royalty reductions, which are incurred or accrued in a Calendar Quarter and are not deducted in such Calendar Quarter due to the limitation set forth above in this Section 6.6.4(f9.5(e), to any subsequent Calendar Quarter(s) and shall begin applying such reduction to such royalties as soon as practicable and continue applying such reduction on a Calendar Quarterly basis thereafter until fully deducted, in all cases subject to the limitation set forth above in this Section 6.6.4(f9.5(e).

Appears in 1 contract

Samples: License Agreement (Agios Pharmaceuticals Inc)

Cumulative Effect of Royalty Reductions. In no event shall the royalty reductions described in this Section 6.6.4Sections 6.2 (a), (c), (d) and (e), alone or together, reduce the royalties payable by Celgene XXXXXX for a Binder Program Product in a country in any given Calendar Quarter pursuant to Section 6.2(a) to less than [***] percent ([***]%) of the amounts otherwise payable by Celgene XXXXXX for such a given Calendar QuarterQuarter pursuant to Section 6.2(a). Celgene XXXXXX may carry over and apply any such royalty reductions, reductions which are incurred or accrued in a Calendar Quarter and are not deducted in such Calendar Quarter due to the limitation set forth above in this Section 6.6.4(f)Quarter, to any subsequent Calendar Quarter(s) ), and shall begin applying such reduction to such royalties as soon as practicable and continue applying such reduction on a Calendar Quarterly basis thereafter until fully deducted, in all cases subject to the limitation set forth above in this Section 6.6.4(f)thereafter.

Appears in 1 contract

Samples: Exclusive License Agreement (Allarity Therapeutics, Inc.)

Cumulative Effect of Royalty Reductions. In no event shall the royalty reductions described in this Section 6.6.49.5, alone or together, reduce the royalties payable by Celgene BeiGene for a Binder Program Product in a country in any given Calendar Quarter to less than [***] percent ([***]%) of the amounts otherwise payable by Celgene BeiGene for such Product in such country in such Calendar Quarter. Celgene BeiGene may carry over and apply any such royalty reductions, which are incurred or accrued in a Calendar Quarter and are not deducted in such Calendar Quarter due to the limitation set forth above in this Section 6.6.4(f9.5(g), to any subsequent Calendar Quarter(s) and shall begin applying such reduction to such royalties as soon as practicable and continue applying such reduction on a Calendar Quarterly Quarter basis thereafter until fully deducted, in all cases subject to the limitation set forth above in this Section 6.6.4(f9.5(g).

Appears in 1 contract

Samples: Development and Collaboration Agreement (BioAtla, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.